Cargando…

Tumour Promotion in Mouse Skin by Sclerosing Agents

Detalles Bibliográficos
Autores principales:	Salaman, M. H., Glendenning, O. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1957
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2073879/ https://www.ncbi.nlm.nih.gov/pubmed/13499793

Ejemplares similares

Incomplete Carcinogens: Ethyl Carbamate (Urethane) as an Initiator of Skin Tumour Formation in the Mouse
por: Salaman, M. H., et al.
Publicado: (1953)

A Quantitative Study of the Power and Persistence of the Tumour-initiating Effect of Ethyl Carbamate (Urethane) on Mouse Skin
por: Roe, F. J. C., et al.
Publicado: (1954)

Further Tests for Tumour-Initiating Activity: N,N-DI-(2-Chloroethyl)-P-Aminophenylbutyric Acid (CB1348) as an Initiator of Skin Tumour Formation in the Mouse
por: Salaman, M. H., et al.
Publicado: (1956)

The Development of Malignant Tumours of Mouse Skin after “Initiating” and “Promoting” Stimuli. II. The Influence of Alternate Applications of Croton Oil on Malignant Tumour-production by Repeated Applications of Dilute 9, 10-Dimethyl-1, 2-Benzanthracene (DMBA)
por: Salaman, M. H., et al.
Publicado: (1956)

The Development of Malignant Tumours of Mouse Skin after “Initiating” and “Promoting” Stimuli. IV. Comparison of the Effects of Single and Divided Initiating Doses of 9, 10-Dimethyl-1, 2-Benzanthrene (DMBA)
por: Salaman, M. H., et al.
Publicado: (1956)

The Histology of Co-Carcinogenesis in Mouse Skin
por: Salaman, M. H., et al.
Publicado: (1951)

The Carcinogenicity of β-Propiolactone for Mouse-Skin
por: Roe, F. J. C., et al.
Publicado: (1956)

The Early Development of Tumours in Mice Inoculated with a Cell-Free Filtrate of Mouse Leukaemic Tissue
por: Salaman, M. H.
Publicado: (1959)

Further Studies on Incomplete Carcinogenesis: Triethylene Melamine (T.E.M.), 1,2-Benzanthracene and β-Propiolactone, as Initiators of Skin Tumour Formation in the Mouse
por: Roe, F. J. C., et al.
Publicado: (1955)

Sclerosing Angioma—A Non-Melanotic Pigmented Tumour of the Skin
por: Dawson, E. K.
Publicado: (1948)

Studies on Co-carcinogenesis. SH-Reactors and other Substances Tested for Co-carcinogenic action in Mouse Skin
por: Gwynn, R. H., et al.
Publicado: (1953)

Haemagglutination by Extracts of Tumours and of Some Normal Tissues
por: Salaman, M. H.
Publicado: (1948)

The Effects of Tumour Initiating Agents on Mouse Skin Sulphydryl Levels
por: Calcutt, G., et al.
Publicado: (1962)

Incomplete Carcinogens in Cigarette Smoke Condensate: Tumour-Promotion by a Phenolic Fraction
por: Roe, F. J. C., et al.
Publicado: (1959)

Sclerosing peritonitis due to practolol simulating an ovarian tumour.
por: Dunlop, J. M., et al.
Publicado: (1976)

Pharmacological immunosuppressive agents.
por: Salaman, J. R.
Publicado: (1981)

Pathophysiological Mechanisms in Sclerosing Skin Diseases
por: Eckes, Beate, et al.
Publicado: (2017)

Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis
por: Kirstein, Martha M, et al.
Publicado: (2020)

The Effect of Tumours, of Leukaemia, and of Some Viruses Associated with them, on the Plasma Lactic Dehydrogenase Activity of Mice
por: Adams, D. H., et al.
Publicado: (1961)

TFE3 is a Novel Biomarker of Ovarian Sclerosing Stromal Tumours
por: Zhao, Li, et al.
Publicado: (2023)

Sclerosing stromal tumour of the ovary: A case report and the review of literature
por: Özdemir, Özhan, et al.
Publicado: (2014)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

Tumours of Many Sites Induced by Injection of Chemical Carcinogens into Newborn Mice, A Sensitive Test for Carcinogenesis: The Implications for Certain Immunological Theories
por: Roe, F. J. C., et al.
Publicado: (1961)

Inhibitory Effects of Gymnema (Gymnema sylvestre) Leaves on Tumour Promotion in Two-Stage Mouse Skin Carcinogenesis
por: Yasukawa, Ken, et al.
Publicado: (2014)

Effects of sclerosing agents on head and neck hemangiomas: A systematic review
por: Stuepp, Rúbia-Teodoro, et al.
Publicado: (2019)

Defining the clonal dynamics leading to mouse skin tumour initiation
por: Sánchez-Danés, Adriana, et al.
Publicado: (2016)

Surveillance of Subacute Sclerosing Panencephalitis
por: Bellman, M. H., et al.
Publicado: (1978)

Skin Tumours
por: Khandpur, Sujay, et al.
Publicado: (2012)

An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion
por: Beck, Tim N., et al.
Publicado: (2019)

Methylcholanthrene carcinogens in the Swiss albino mouse in relation to differential oncogenesis of skin tumours.
por: Bhisey, R. A., et al.
Publicado: (1966)

The Development of Malignant Tumours of Mouse Skin after “Initiating” and “Promoting” Stimuli. III. The Carcinogenic Action of Croton Oil
por: Roe, F. J. C.
Publicado: (1956)

Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984)

Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis
por: Tardelli, Matteo, et al.
Publicado: (2019)

Ethanolamine oleate vs. absolute ethanol as sclerosing agents for treating symptomatic simple renal cysts
por: El-Kader, Osman Abd, et al.
Publicado: (2014)

Sclerosing Melanocytic Lesions (sclerosing Melanomas with Nevoid Features and Sclerosing Nevi with Pseudomelanomatous Features) – An Analysis of 90 Lesions
por: Grcar-Kuzmanov, Biljana, et al.
Publicado: (2018)

Usefulness of a Low-Dose Sclerosing Agent for the Treatment of Vascular Lesions in the Tongue
por: Lim, Taeil, et al.
Publicado: (2023)

Sclerosing mesenteritis
por: Chen, Chien-Chin, et al.
Publicado: (2018)

Tumours of the Skin
por: Bodenham, D. C.
Publicado: (1966)

Congenital Tumours of Skin
por: Greig, David M.
Publicado: (1916)

Hepatic sclerosed hemangioma and sclerosing cavernous hemangioma: a radiological study
por: Jia, Cuiyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gbsc2l8aumd6iemu0udom54g08